Spark Biomedical, Inc. is a medical device company developing non-invasive neurostimulation solutions for opioid withdrawal and addiction.
Spark Biomedical has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Spark Biomedical's investors include National Institute on Drug Abuse (NIDA), Pathway to Cures, WAVE Ventures, Texas A&M Innovation.
Spark Biomedical is headquartered in Houston, United States.
Spark Biomedical, Inc. is a medical device company developing non-invasive neurostimulation solutions for opioid withdrawal and addiction.
Spark Biomedical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spark Biomedical — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/spark-biomedical. Accessed September 15, 2026.
VCBacked. (2025). Spark Biomedical — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/spark-biomedical
{{cite web |title=Spark Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/spark-biomedical |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated